Activation of rapamycin-sensitive TORC1 by endomembrane amino acid transporters

内膜氨基酸转运蛋白激活雷帕霉素敏感的TORC1

基本信息

  • 批准号:
    8021215
  • 负责人:
  • 金额:
    $ 32.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-01-01 至 2015-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The target of rapamycin complex 1 (TORC1) plays a prominent role in a ubiquitously conserved signal transduction cascade that responds to nutrients and growth factor cues to control cell growth and proliferation. Dysregulation of the TORC1 cascade results in multiple types of human malignancies. The central TORC1 members are the Tor protein kinases, which were discovered in the yeast Saccharomyces cerevisiae, a model system that has been crucial in elucidating the TORC1 signaling cascade. Based on its potent antiproliferative activity, rapamycin is in use in several clinical areas including immunosuppression, cancer chemotherapy, and interventional cardiology. The TORC1 pathway remains partially characterized despite much study. We uncovered an unexpected role for the endomembrane vesicular trafficking system in regulating TORC1 signaling in yeast; mutations in protein complexes with roles in vesicular trafficking and protein sorting in combination with mutation of the nonessential Tor1 kinase, render cells inviable or severely growth impaired. We demonstrated that the HOPS complex is required to provide amino acid homeostasis for efficient TORC1 signaling and for normal expression of TORC1-governed genes. These studies also revealed a novel facet in the rapamycin mechanism of action: rapamycin bypasses vesicular trafficking events to activate TORC1- controlled transactivators. Moreover, we showed that mutations in the Ego complex (EGOC) compromise TORC1 signaling and both EGOC and TORC1 activity are required for optimal cell growth. The EGOC possesses evolutionary conserved amino acid-sensitive GTPase subunits and orthologs of these (Gtr1,2 and RagA-D proteins) mediate TORC1 activation in yeast, insect, and mammalian cells. However, the identity of the amino acid sensors and the underlying mechanisms by which amino acids activate EGOC GTPase are unknown. Intriguingly, TORC1 and the EGOC colocalize to endomembranes including those of endosomes and vacuoles, along with vacuolar amino acid transporters. The aims of this proposal are: 1) to elucidate the roles and underlying mechanism by which the endomembrane system enables TORC1 signaling and 2) to determine whether the vacuolar amino acid transporters, which are conserved in mammals, are integrated into the molecular cascade that conveys amino acid signals to evoke TORC1 activation. Our working model is that the endomembrane network provides a platform to facilitate molecular interactions that activate and enable TORC1 signaling. Similar to yeast TORC1, mammalian TORC1 is also localized to endomembranes, in particular lysosomes, which are the counterparts of yeast vacuoles. Thus, we submit that our research will continue to uncover fundamental, conserved TORC1 signaling aspects that could be directly extrapolated to mammalian models and guide pharmacological intervention in select TORC1 pathway defects in human cancer and other diseases. PUBLIC HEALTH RELEVANCE: The rapamycin sensitive-TORC1 is the central component of an evolutionary-conserved signaling cascade that in response to nutrients and growth factors regulates cell growth and proliferation. Defects in mTORC1 signaling lead to cancer and other human diseases. Rapamycin and its analogs are being developed as therapeutic agents for the treatment of a wide range of malignances and could also find indication in cognitive- and aging-related diseases. The model yeast S. cerevisiae has been crucial in the discovery of the TORC1 pathway and elucidation of rapamycin mechanism of action. Characterization of this pathway in yeast is continuing to reveal basic aspects of TORC1 signaling that could foster analogous studies in mammals and lead to improved anticancer therapies.
描述(由申请人提供):雷帕霉素复合物1(TORC 1)的靶标在普遍保守的信号转导级联中起着重要作用,该信号转导级联响应营养素和生长因子信号以控制细胞生长和增殖。TORC 1级联的失调导致多种类型的人类恶性肿瘤。TORC 1的核心成员是Tor蛋白激酶,它是在酵母酿酒酵母中发现的,这是一种在阐明TORC 1信号级联中至关重要的模型系统。基于其有效的抗增殖活性,雷帕霉素被用于几个临床领域,包括免疫抑制,癌症化疗和介入心脏病学。尽管进行了大量研究,但TORC 1通路仍具有部分特征。我们发现了一个意想不到的作用,内膜囊泡运输系统在调节TORC 1信号在酵母中的蛋白质复合物的突变与囊泡运输和蛋白质分选的作用,结合突变的非必需的Tor 1激酶,使细胞无法生存或严重生长受损。我们证明,HOPS复合物是必需的,以提供有效的TORC 1信号和正常表达的TORC 1控制的基因的氨基酸稳态。这些研究还揭示了雷帕霉素作用机制的一个新方面:雷帕霉素绕过囊泡运输事件来激活TORC 1控制的反式激活因子。此外,我们发现,自我复合物(EGOC)中的突变会损害TORC 1信号传导,并且EGOC和TORC 1活性都是最佳细胞生长所必需的。EGOC具有进化上保守的氨基酸敏感性GTR亚基,并且这些(GTR 1、2和RagA-D蛋白)的直系同源物介导酵母、昆虫和哺乳动物细胞中的TORC 1活化。然而,氨基酸传感器的身份和氨基酸激活EGOC GT3的潜在机制尚不清楚。 有趣的是,TORC 1和EGOC共定位于内膜,包括内体和空泡的内膜,沿着空泡氨基酸转运蛋白。本研究的目的是:1)阐明内膜系统激活TORC 1信号的作用和潜在机制; 2)确定哺乳动物中保守的液泡氨基酸转运蛋白是否整合到传递氨基酸信号以激活TORC 1的分子级联中。我们的工作模型是内膜网络提供了一个平台,以促进分子相互作用,激活和启用TORC 1信号。与酵母TORC 1类似,哺乳动物TORC 1也定位于内膜,特别是溶酶体,其是酵母液泡的对应物。因此,我们提出,我们的研究将继续揭示基本的,保守的TORC 1信号传导方面,可以直接外推到哺乳动物模型,并指导药物干预选择TORC 1通路缺陷在人类癌症和其他疾病。 公共卫生相关性:雷帕霉素敏感的TORC 1是进化保守的信号级联反应的核心组成部分,其响应于营养物质和生长因子调节细胞生长和增殖。mTORC 1信号传导的缺陷导致癌症和其他人类疾病。雷帕霉素及其类似物正被开发为用于治疗广泛的恶性肿瘤的治疗剂,并且还可以在认知和衰老相关疾病中找到适应症。模式酵母S.在发现TORC 1通路和阐明雷帕霉素作用机制方面,酿酒酵母的作用是至关重要的。酵母中这一途径的表征正在继续揭示TORC 1信号传导的基本方面,这可能会促进哺乳动物中的类似研究,并导致改进的抗癌疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARIA E CARDENAS-CORONA其他文献

MARIA E CARDENAS-CORONA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARIA E CARDENAS-CORONA', 18)}}的其他基金

Activation of rapamycin-sensitive TORC1 by endomembrane amino acid transporters
内膜氨基酸转运蛋白激活雷帕霉素敏感的TORC1
  • 批准号:
    8403821
  • 财政年份:
    2011
  • 资助金额:
    $ 32.58万
  • 项目类别:
Activation of rapamycin-sensitive TORC1 by endomembrane amino acid transporters
内膜氨基酸转运蛋白激活雷帕霉素敏感的TORC1
  • 批准号:
    8206561
  • 财政年份:
    2011
  • 资助金额:
    $ 32.58万
  • 项目类别:
Activation of rapamycin-sensitive TORC1 by endomembrane amino acid transporters
内膜氨基酸转运蛋白激活雷帕霉素敏感的TORC1
  • 批准号:
    8602069
  • 财政年份:
    2011
  • 资助金额:
    $ 32.58万
  • 项目类别:
IDENTIFICATION OF TOR INTERACTING PROTEINS
Tor 相互作用蛋白的鉴定
  • 批准号:
    7420664
  • 财政年份:
    2006
  • 资助金额:
    $ 32.58万
  • 项目类别:
Signaling mechanisms by the rapamycin target: Tor kinase
雷帕霉素靶点的信号传导机制:Tor 激酶
  • 批准号:
    6911931
  • 财政年份:
    2005
  • 资助金额:
    $ 32.58万
  • 项目类别:
Signaling mechanisms by the rapamycin target: Tor kinase
雷帕霉素靶标的信号传导机制:Tor 激酶
  • 批准号:
    7367851
  • 财政年份:
    2005
  • 资助金额:
    $ 32.58万
  • 项目类别:
Signaling mechanisms by the rapamycin target: Tor kinase
雷帕霉素靶标的信号传导机制:Tor 激酶
  • 批准号:
    7554129
  • 财政年份:
    2005
  • 资助金额:
    $ 32.58万
  • 项目类别:
Signaling mechanisms by the rapamycin target: Tor kinase
雷帕霉素靶标的信号传导机制:Tor 激酶
  • 批准号:
    7185140
  • 财政年份:
    2005
  • 资助金额:
    $ 32.58万
  • 项目类别:
Signaling mechanisms by the rapamycin target: Tor kinase
雷帕霉素靶标的信号传导机制:Tor 激酶
  • 批准号:
    7032435
  • 财政年份:
    2005
  • 资助金额:
    $ 32.58万
  • 项目类别:
IDENTIFICATION OF TOR INTERACTING PROTEINS
Tor 相互作用蛋白的鉴定
  • 批准号:
    6979523
  • 财政年份:
    2004
  • 资助金额:
    $ 32.58万
  • 项目类别:

相似海外基金

Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
  • 批准号:
    BB/Y006380/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.58万
  • 项目类别:
    Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
  • 批准号:
    24K17112
  • 财政年份:
    2024
  • 资助金额:
    $ 32.58万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
  • 批准号:
    2300890
  • 财政年份:
    2023
  • 资助金额:
    $ 32.58万
  • 项目类别:
    Continuing Grant
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
  • 批准号:
    23K06918
  • 财政年份:
    2023
  • 资助金额:
    $ 32.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
  • 批准号:
    23K05758
  • 财政年份:
    2023
  • 资助金额:
    $ 32.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
  • 批准号:
    23K04668
  • 财政年份:
    2023
  • 资助金额:
    $ 32.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
  • 批准号:
    2888395
  • 财政年份:
    2023
  • 资助金额:
    $ 32.58万
  • 项目类别:
    Studentship
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
  • 批准号:
    10761044
  • 财政年份:
    2023
  • 资助金额:
    $ 32.58万
  • 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
  • 批准号:
    10728925
  • 财政年份:
    2023
  • 资助金额:
    $ 32.58万
  • 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
  • 批准号:
    10757309
  • 财政年份:
    2023
  • 资助金额:
    $ 32.58万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了